Health

Moderna Shares Report of Delayed Coronavirus Trial

Moderna’s MRNA shares were lower after a news report said biotechnology was delaying the start of a Phase III trial of its experimental coronavirus vaccine. Shares of the Cambridge, Massachusetts company in the latest check fell 5.4% to $ 58.25. Healthcare website Stat News said Moderna was making changes to …

Read More »